It's the company's 4th acquisition since March 2012.
The FDA approved Tc 99m tilmanocept, a radioactive diagnostic imaging agent.
$60 million will fund concussion and other brain trauma research.
ECR panelists examine the latest research.
Driven by gains in ambulatory health care services.
One health system doubled screening rates and lowered costs.
At ECR 2013, Gabriel Krestin urges rads to get on board with personalized medicine.
Technology will help interventional cardiologists perform novel procedures.
Lantheus Medical Imaging announced the appointment of Dr. Cesare Orlandi as CMO.
Partnership will leverage companies' combined technologies.
Will they be taxed under the new law?
The FDA's budget is on the chopping block.
Companies unveil MARZ at HIMSS.
Company says it will help assess breast density.
The Versa HD is designed to deliver higher doses of radiation to treat cancers.
Signos RT is a second generation portable ultrasound device.
H.R. 846 would stop cuts to diagnostic imaging services for Medicare providers.
Repealing the health law's tax amid looming budget cuts is priority.
Health care cuts loom large under sequestration.
Strowig has been promoted to Chief Operating Officer of TeraMedica.
Despite growth, many facilities remain in the dark about how to gear up.
MITA reports progress on working with Brazilian regulators to remove barriers for OEMs.
Letter from the online editor for March.
ECRI urges hospitals to use correct protocol for investigating device accidents.
InSightec's ExAblate Neuro begins pivotal Phase III.
ECRI Institute released its list of what hospital executives should be keeping an eye on this year.
A new analysis found review times sped up after years of lengthened review times.
Patients without traditional risk factors could benefit from CT angiography.
The event, which drew roughly 200, focused on the future of the pricey cancer treatment.
Companies officially announce OEM cooperation.
Some of the criteria might include amyloid imaging.
Surveyed men say they are satisfied with proton therapy treatment.
Move will help expand Crothall's clinical equipment division and imaging capabilities.
New study finds that 13.8 million will have Alzheimer's by 2050.
House bill would prevent a premature closing of the Federal Helium Reserve.
Ted Kremer, executive director of the Rochester RHIO, answers our questions.
Analysts warn that potential cuts on March 1 could impact FDA review processes.
Heart disease is the leading cause of death for women.
New study finds diagnostic errors, not communication, the main reason for suits.
VMAT delivers radiation over a continuous arc around the patient.
A new study finds that the benefits of CT actually outweigh the risks in sick young adults.
Encourage CMS to weigh the totality of evidence.
Growth in ambulatory health care services within the sector.
Letter from the online editor: February 2013
NIH study finds advanced scanner from Toshiba beneficial in dose reduction for CCTA.
The latest effort to push Samsung into the medical equipment marketplace.
First medical device tax payment resolves industry's commitment to keep fighting.
Concern that device companies are shifting costs of new tax to hospitals.
Building evidence for treating pediatric and prostate cancers.
MD Anderson joins Philips, Elekta research consortium.